Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid

Oplon-Pure Science

Status and phase: Completed; Phase 2; Phase 1

Conditions: Acne Vulgaris

Treatments: Device: Sham patch; Device: OPLON active patch

Study type: Interventional

Funder types: Industry

Identifiers

NCT01179633

OP001

Details and patient eligibility

About

The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.

Full description

Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.

Enrollment: 35 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Acne Vulgaris
• Over 18 years
• Signing informed consent

Exclusion criteria

• Active treatment of acne
• Change in hormonal therapy
• Antibiotic treatment in a week prior to the experiment
• Sensitive skin
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

35 participants in 2 patient groups, including a placebo group

Oplon Active Patch

Active Comparator group

Treatment:

Device: OPLON active patch

Placebo patch

Placebo Comparator group

Treatment:

Device: Sham patch